Tag: cardiac biomarkers testing market demand

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

How is the Growth Rate of the Cardiac Biomarkers Testing Market Estimated for 2024-2033?

The market size for cardiac biomarkers testing has seen swift expansion in the previous years. It is projected to rise from a value of $12.15 billion in 2023 to $13.63 billion the following year, reflecting a compound annual growth rate (CAGR) of 12.1%. The remarkable growth during the historic period is attributed to factors such as the growing prevalence of cardiovascular diseases, an aging demographic, enhanced awareness and educational campaigns, government schemes, health care policies, and an increase in healthcare spending.

The market size of testing for cardiac biomarkers is anticipated to experience a significant surge in the coming years. It is projected to reach $21.31 billion in 2028, with a Compound Annual Growth Rate (CAGR) of 11.8%. The expansion during the projection period is linked to personalized medicine, an escalating global load of cardiovascular diseases, the inclusion of artificial intelligence (AI) in diagnostics, the growth of point-of-care testing, and a heightened focus on early detection of diseases. The forecast period is likely to witness major trends such as advancements in technology, progress in AI-facilitated diagnostics, growth of point-of-care testing (POCT), development of multiplexing capabilities, and the discovery and validation of biomarkers.

Claim Your Free Sample of the Global Cardiac Biomarkers Testing Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp

What Key Drivers Are Propelling the cardiac biomarkers testing Market’s Growth?

The cardiac biomarkers testing market is predicted to grow due to the rising occurrences of cardiovascular ailments. These conditions affect either the heart or blood vessels and the cardiac biomarker tests are crucial in determining the quantities of biomarkers in the body which helps to quickly ascertain the seriousness and scope of a heart attack. As the prevalence of these conditions increases, so will the need for cardiac biomarker tests. For example, the American College of Cardiology, a professional medical society from the US, suggested in August 2022, that the expected rates of cardiovascular risks and illnesses are likely to significantly escalate in the US by 2060. It’s thus, the growing prevalence of these cardiovascular conditions that’s propelling the advancement of the cardiac biomarkers testing market.

What Are the Distinct Segments of the Cardiac Biomarkers Testing Market?

1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified albumin (IMA), Other Biomarkers Types

2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications

3) By End-User: Hospitals, Specialty Clinics

Which New Trends Are Making Waves in the Cardiac Biomarkers Testing Market?

Key innovations in products serve as a trending factor growing in popularity within the cardiac biomarker testing market. Mainstream companies in this industry are honing their focus on the creation of novel products to maintain their standing in the market. For instance, in October 2021, Siemens Healthcare GmbH, a medical technology firm based in Germany, unveiled the Atellica VTLi Patient-Side Immunoassay Analyzer. The distinct feature of this product, which sets it apart, is its high-sensitivity troponin I test obtained from a single fingerstick sample. This product allows clinicians and other medical professionals to improve patient outcomes by providing a quick and reliable diagnosis of a heart attack within an eight-minute timeframe.

Order Now for Fast Delivery of Your Cardiac Biomarkers Testing Market Report!

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Which Regions Are Significant to the Growth of the Cardiac Biomarkers Testing Market?

North America was the largest region in the cardiac biomarkers testing market in 2023. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Cardiac Biomarkers Testing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the cardiac biomarkers testing market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Cardiac Biomarkers Testing Market Include

1. Cardiac Biomarkers Testing Market Executive Summary

2. Cardiac Biomarkers Testing Market Segments

3. Cardiac Biomarkers Testing Market Size And Template Market Growth Rate

4. Key Cardiac Biomarkers Testing Market Trends

5. Major Cardiac Biomarkers Testing Market Drivers

……

25. Key Mergers And Acquisitions In The Cardiac Biomarkers Testing Market

26. Top Cardiac Biomarkers Testing Companies

27. Cardiac Biomarkers Testing Market Opportunities And Strategies

28. Cardiac Biomarkers Testing Market, Conclusions And Recommendations

29. Appendix

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The cardiac biomarkers testing market has experienced rapid expansion in recent years, driven by several factors including increasing incidence of cardiovascular diseases, aging population, awareness initiatives, government policies, and healthcare expenditure.

Market Overview

• The market size reached $12.15 billion in 2023 and is projected to reach $13.63 billion in 2024, growing at a CAGR of 12.1%.
• In the forecast period, the market is expected to grow to $21.31 billion in 2028, with a CAGR of 11.8%.

Factors Driving Growth

1. Rising Prevalence of Cardiovascular Diseases
   • Cardiovascular diseases are on the rise globally, leading to an increased demand for cardiac biomarker testing solutions.
   • Organizations like the American College of Cardiology predict significant increases in cardiovascular risk factors and diseases, emphasizing the need for effective testing solutions.
2. Elevating Cardiovascular Care with Innovative Biomarkers
   • Major companies are focusing on innovative cardiac biomarker products to enhance patient outcomes and drive market growth.
   • Troponin I and NT-proBNP cardiac biomarkers are gaining attention for their sensitivity, accuracy, and reliability in identifying myocardial damage.
3. Strategic Acquisitions and Expansions
   • Companies like Shenzhen Mindray Bio-Medical Electronics Co. Ltd. are expanding their global footprint and innovating through strategic acquisitions.
   • The acquisition of HyTest Invest Oy strengthens capabilities in research and development, supporting continued innovation in the cardiac biomarkers space.

Market Segmentation

1. Biomarkers Type
   • Includes Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified albumin (IMA), and Other Biomarkers Types.
2. Application
   • Applications span Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, and Other Applications.
3. End-User
   • Target end-users include Hospitals and Specialty Clinics.

Regional Insights

• North America emerged as the largest region in the cardiac biomarkers testing market in 2023, reflecting the market’s global presence and growth potential.

Future Trends and Opportunities

• Technological Advancements: Continued advancements in technology will shape the future of cardiac biomarker testing, enhancing accuracy and efficiency.
• AI-Assisted Diagnostics: Integration of artificial intelligence will revolutionize diagnostics, enabling faster and more accurate detection of cardiovascular diseases.
• Point-of-Care Testing Growth: The expansion of point-of-care testing facilities will increase accessibility to cardiac biomarker testing, especially in remote or underserved areas.
• Multiplexing Capabilities: Innovations in multiplexing will enable simultaneous detection of multiple biomarkers, providing comprehensive diagnostic insights.
• Biomarker Discovery and Validation: Ongoing research in biomarker discovery and validation will lead to the development of novel diagnostic tools and therapies.

Conclusion
The cardiac biomarkers testing market is poised for significant growth driven by the rising prevalence of cardiovascular diseases, technological advancements, and strategic initiatives by key players. With continued innovation and investment, the market is expected to expand further, catering to the evolving needs of healthcare providers and patients globally.

View More On The Cardiac Biomarkers Testing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Request A Sample Of The Global Cardiac Biomarkers Testing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=9436&type=smp